Understand what your pcos results really mean
See your biomarkers in context with a comprehensive panel.
- CLIA-certified labs
- HIPAA compliant
- Personalized health protocol
Your ultrasound report mentions a string of pearls pattern and you're not sure what that means. It sounds alarming, but it's actually a specific arrangement of follicles that doctors look for when evaluating PCOS. Understanding what the pattern does and doesn't tell you can save you unnecessary worry.
What the string of pearls pattern actually shows
The string of pearls appearance describes multiple small follicles, each measuring 2 to 9 millimeters in diameter, arranged in a peripheral ring around the ovary's outer cortex. On a transvaginal ultrasound, these follicles appear as small, dark (anechoic) circles because they're fluid-filled sacs. The pattern earned its name because the follicles line up like beads on a necklace when viewed in cross-section.
These are not cysts. They're antral follicles, the same structures that develop each month during a normal menstrual cycle. In a typical ovulatory cycle, one follicle matures and releases an egg while the others regress. In PCOS, hormonal imbalances prevent any single follicle from reaching full maturity. Instead, multiple follicles begin developing but arrest at an early stage, accumulating around the ovary's periphery. The result is a higher-than-normal follicle count, typically 20 or more per ovary when using high-resolution transvaginal ultrasound.
The Rotterdam criteria, established in 2003 and updated in 2018, define polycystic ovary morphology as either 20 or more follicles per ovary or an ovarian volume greater than 10 cubic centimeters. The follicle count threshold was raised from 12 to 20 as ultrasound technology improved, allowing clinicians to visualize smaller structures more accurately.
How PCOS disrupts follicle development and ovarian structure
The string of pearls pattern reflects what happens when the hormonal signals that regulate ovulation go awry. In PCOS, elevated insulin and luteinizing hormone (LH) levels, combined with relative deficiency of follicle-stimulating hormone (FSH), create an environment where follicles start to mature but never finish the process.
Hormonal disruption at the follicular level
Insulin resistance, present in up to 70% of people with PCOS, drives excess androgen production by ovarian theca cells . These androgens interfere with normal follicle maturation. High LH levels further stimulate androgen synthesis, while insufficient FSH means no single follicle receives the signal to become dominant and ovulate. The result is a cohort of small, arrested follicles that persist cycle after cycle.
Ovarian stromal changes
Beyond the follicles themselves, the ovarian stroma (the supportive tissue between follicles) becomes hyperechoic on ultrasound, meaning it appears brighter than normal. This increased echogenicity reflects stromal hypertrophy and increased vascularity driven by chronic androgen exposure. The stroma-to-total ovarian area ratio correlates with biochemical hyperandrogenism, making it a useful secondary marker when evaluating PCOS severity.
Ovarian volume expansion
Polycystic ovaries are often enlarged, with volumes exceeding 10 cubic centimeters. This expansion results from both the accumulation of multiple follicles and stromal thickening. Ovarian volume alone can meet diagnostic criteria for polycystic ovary morphology even when follicle count is borderline, though the two findings typically occur together.
What drives the string of pearls pattern
Insulin resistance and hyperinsulinemia
Elevated insulin levels amplify LH-driven androgen production in the ovaries. Insulin also suppresses sex hormone-binding globulin (SHBG) production in the liver, increasing free testosterone levels in circulation. This creates a feedback loop where high androgens further impair insulin sensitivity, perpetuating both metabolic dysfunction and ovulatory disruption.
Elevated LH-to-FSH ratio
In PCOS, the pituitary gland secretes LH at higher-than-normal levels relative to FSH. This skewed ratio favors androgen synthesis over estrogen production and prevents any single follicle from achieving dominance. Without a dominant follicle, ovulation doesn't occur, and the arrested follicles remain visible on ultrasound.
Chronic anovulation
When ovulation fails to occur regularly, the ovaries don't undergo the normal cyclical changes that clear out immature follicles. Instead, these follicles persist, creating the characteristic polycystic appearance. The longer anovulation continues, the more pronounced the ultrasound findings become.
Genetic and epigenetic factors
PCOS has a strong hereditary component. Variants in genes regulating insulin signaling, androgen synthesis, and gonadotropin receptor function increase susceptibility to the condition. Environmental factors, including diet, stress, and endocrine-disrupting chemical exposure, can modify gene expression and influence whether someone with genetic predisposition develops the full syndrome.
Why the same ultrasound findings look different across individuals
Polycystic ovary morphology without PCOS
Up to 20 to 30% of reproductive-age individuals with regular ovulatory cycles have polycystic ovaries on ultrasound but no other features of PCOS. These individuals may have a higher baseline follicle count due to genetic variation in ovarian reserve or may represent a milder phenotype that doesn't progress to full syndrome. Polycystic ovary morphology alone, without hyperandrogenism or ovulatory dysfunction, doesn't warrant a PCOS diagnosis or treatment.
Age-related changes in ovarian morphology
Follicle count and ovarian volume decline with age. The threshold for defining polycystic ovaries may need adjustment in individuals over 30, as normal age-related follicle depletion can mask the polycystic pattern. Conversely, younger individuals may show more pronounced ultrasound findings even with milder hormonal abnormalities.
Body composition and metabolic phenotype
Insulin resistance severity varies widely among people with PCOS. Those with higher body mass index and central adiposity tend to have more severe metabolic dysfunction, which amplifies ovarian androgen production and may correlate with more pronounced ultrasound findings. However, lean individuals with PCOS can also display the string of pearls pattern, driven more by primary ovarian dysfunction than by insulin resistance.
PCOS phenotype variation
The Rotterdam criteria recognize four PCOS phenotypes based on which two of three criteria are present: hyperandrogenism, ovulatory dysfunction, and polycystic ovary morphology. Individuals with hyperandrogenism and anovulation but normal-appearing ovaries still have PCOS. Conversely, those with polycystic ovaries and irregular cycles but no clinical or biochemical hyperandrogenism represent a milder phenotype with different metabolic risk profiles.
Test 100+ biomarkers from home
One blood draw. A full picture of your health, explained in plain language.
Test 100+ biomarkers from home
One blood draw. A full picture of your health, explained in plain language.
Connecting ultrasound findings to metabolic and hormonal data
The string of pearls pattern on ultrasound is one piece of diagnostic information. It becomes clinically meaningful when interpreted alongside hormonal and metabolic markers that reveal the underlying drivers of ovarian dysfunction.
Testosterone and free androgen index quantify hyperandrogenism, while LH and FSH levels reveal the gonadotropin imbalance driving follicular arrest. Fasting insulin and glucose assess insulin resistance, while hemoglobin A1c tracks longer-term glycemic control. Anti-Mullerian hormone (AMH), secreted by small antral follicles, is often elevated in PCOS and correlates with follicle count on ultrasound.
Lipid panels, including triglycerides and HDL cholesterol, help assess cardiovascular risk, which is elevated in PCOS due to chronic inflammation and metabolic dysfunction. High-sensitivity C-reactive protein (hs-CRP) provides a marker of systemic inflammation. Tracking these biomarkers over time reveals whether interventions are improving the metabolic environment that drives ovarian dysfunction, even before ultrasound findings normalize.
Directional trends matter more than single measurements. A declining AMH level, improving insulin sensitivity, or normalizing LH-to-FSH ratio suggests that the hormonal imbalances perpetuating the string of pearls pattern are resolving, even if the ultrasound appearance lags behind.
How Superpower helps you track the full picture
Understanding what's happening at the hormonal and metabolic level gives you more control than an ultrasound image alone. Superpower's 100+ biomarker panel measures testosterone, insulin, glucose, AMH, LH, FSH, lipids, and inflammatory markers in a single draw, so you can see how the drivers of ovarian dysfunction are shifting over time. Tracking these markers alongside ultrasound findings helps you and your clinician make informed decisions about interventions, whether that's lifestyle modification, metabolic support, or hormonal therapy.
Frequently Asked Questions
References
- Amisi CA (2022). Markers of insulin resistance in Polycystic ovary syndrome women: An update. *World journal of diabetes*, *13*(3), 129-149. https://doi.org/10.4239/wjd.v13.i3.129
- Van Elswyk ME, Weatherford CA, McNeill SH (2018). A Systematic Review of Renal Health in Healthy Individuals Associated with Protein Intake above the US Recommended Daily Allowance in Randomized Controlled Trials and Observational Studies. *Advances in nutrition (Bethesda, Md.)*, *9*(4), 404-418. https://doi.org/10.1093/advances/nmy026
- Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, Piltonen T, Norman RJ (2018). Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. *Fertility and Sterility*, *110*(3), 364-379. https://doi.org/10.1016/j.fertnstert.2018.05.004
- Pigny P, Jonard S, Robert Y, Dewailly D (2006). Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome. *The Journal of Clinical Endocrinology and Metabolism*, *91*(3), 941-945. https://doi.org/10.1210/jc.2005-2076
- Adams JM, Taylor AE, Crowley WF, Jr, Hall JE (2004). Polycystic ovarian morphology with regular ovulatory cycles: insights into the pathophysiology of polycystic ovarian syndrome. *The Journal of Clinical Endocrinology and Metabolism*, *89*(9), 4343-4350. https://doi.org/10.1210/jc.2003-031600
